Literature DB >> 28638681

Efficacy of extracorporeal shockwave therapy and low-intensity pulsed ultrasound in a rat knee osteoarthritis model: A randomized controlled trial.

Volkan Yılmaz1, Ömer Karadaş2, Taner Dandinoğlu3, Ebru Umay1, Aytül Çakçı1, Arif Kenan Tan3.   

Abstract

OBJECTIVE: This study aims to assess the efficacy of extracorporeal shockwave therapy (ESWT) and low-intensity pulsed ultrasound (LIPUS) on osteoarthritic rat knees.
MATERIAL AND METHODS: Twenty-four rats were divided into 3 groups: group 1-control (n=8), group 2-LIPUS (n=8) and group 3-ESWT (n=8). Cartilage degeneration was provided using mono-iodo-asetate (MIA). One milligram of MIA was delivered to the right knees in group 1 and both knees in group 2 and 3. A 0.09% saline solution was delivered to the left knees in group 1 for control. Twenty-four hours after the delivery, ESWT was applied once on the right knees in the group 2 rats to the medial tibia plateu with a 1 Hz frequency and 800 impulses. LIPUS was applied to the right knees in the group 2 rats to the medial tibia plateu with a 3 mHz frequency and 40 mW/cm2 intensity for 20 minutes over a period of 15 days. Pain scores were measured with a knee bend test. Bone mineral density measurements and scintigraphic bone scans were performed. Histopathological examination was done using a modified Mankin scale.
RESULTS: There was no difference among the right knee subchondral bone osteoblastic activities (p>0.05). The left knee osteoblastic activities in the LIPUS and extracorporeal shockwave therapy (ESWT) groups were higher than those in the control group (p<0.05), but there was no difference between the LIPUS and ESWT groups. There was no difference among the groups for both knee subchondral bone BMD values (p>0.05). The modified Mankin scores of both the right and left knees of the ESWT and LIPUS groups were lower than those of the control group (p<0.05), but there was no difference between the ESWT and LIPUS groups. The pain scores of both knees of the ESWT and LIPUS groups at day 7 were higher than those of the control group (p<0.05), but there was no difference between the ESWT and LIPUS groups. There was no difference among the pain scores of the right knees at day 14 (p<0.05).
CONCLUSION: ESWT and LIPUS have systemic proliferative and regenerative effects on cartilage and tissue.

Entities:  

Keywords:  Extracorporeal shockwave therapy; low-intensity pulsed ultrasound; osteoarthritis

Year:  2017        PMID: 28638681      PMCID: PMC5473443          DOI: 10.5152/eurjrheum.2017.160089

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  27 in total

1.  What makes a shock wave efficient in lithotripsy?

Authors:  B Granz; G Köhler
Journal:  J Stone Dis       Date:  1992-04

Review 2.  Application of shock waves in medicine.

Authors:  M Thiel
Journal:  Clin Orthop Relat Res       Date:  2001-06       Impact factor: 4.176

3.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Authors:  R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg
Journal:  Arthritis Rheum       Date:  1986-08

4.  Chondroprotection in osteoarthritis.

Authors:  C J Lozada; R D Altman
Journal:  Bull Rheum Dis       Date:  1997-11

5.  Extracorporeal shockwave therapy shows chondroprotective effects in osteoarthritic rat knee.

Authors:  Ching-Jen Wang; Lin-Hsiu Weng; Jih-Yang Ko; Yi-Chih Sun; Ya-Ju Yang; Feng-Sheng Wang
Journal:  Arch Orthop Trauma Surg       Date:  2011-03-09       Impact factor: 3.067

6.  The effect of high-energy extracorporeal shock waves on hyaline cartilage of adult rats in vivo.

Authors:  Susanne Mayer-Wagner; Judith Ernst; Markus Maier; Matthias Chiquet; Helga Joos; Peter E Müller; Volkmar Jansson; Birte Sievers; Jörg Hausdorf
Journal:  J Orthop Res       Date:  2010-08       Impact factor: 3.494

7.  Substance P and prostaglandin E2 release after shock wave application to the rabbit femur.

Authors:  Markus Maier; Beate Averbeck; Stefan Milz; Hans Jürgen Refior; Christoph Schmitz
Journal:  Clin Orthop Relat Res       Date:  2003-01       Impact factor: 4.176

8.  Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis.

Authors:  S Sukenik; J Henkin; S Zimlichman; A Skibin; L Neuman; M Pras; J Horowitz; R Shainkin-Kestenbaum
Journal:  J Rheumatol       Date:  1988-06       Impact factor: 4.666

9.  Shock wave treatment shows dose-dependent enhancement of bone mass and bone strength after fracture of the femur.

Authors:  Ching-Jen Wang; Kuender D Yang; Feng-Sheng Wang; Chia-Chen Hsu; Hsiang-Ho Chen
Journal:  Bone       Date:  2004-01       Impact factor: 4.398

10.  Effects of low-intensity pulsed ultrasound and hyperbaric oxygen on human osteoarthritic chondrocytes.

Authors:  Li-Jen Yuan; Chi-Chien Niu; Song-Shu Lin; Chuen-Yung Yang; Yi-Sheng Chan; Wen-Jer Chen; Steve W N Ueng
Journal:  J Orthop Surg Res       Date:  2014-02-05       Impact factor: 2.359

View more
  4 in total

Review 1.  The Effects of the Exposure of Musculoskeletal Tissue to Extracorporeal Shock Waves.

Authors:  Tobias Wuerfel; Christoph Schmitz; Leon L J Jokinen
Journal:  Biomedicines       Date:  2022-05-06

2.  The effect of extracorporeal shock wave therapy on the treatment of moderate to severe knee osteoarthritis and cartilage lesion.

Authors:  Yongming Xu; Kun Wu; Yu Liu; Huan Geng; Haochong Zhang; Shuitao Liu; Hongying Qu; Gengyan Xing
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

3.  Application of low-intensity pulsed therapeutic ultrasound on mesenchymal precursors does not affect their cell properties.

Authors:  Beatriz de Lucas; Laura M Pérez; Aurora Bernal; Beatriz G Gálvez
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

4.  Effects of extracorporeal shock wave therapy in patients with knee osteoarthritis: A cohort study protocol.

Authors:  Xianfei Xie; Jialing Zhu; Hao Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.